The courses are divided into special lectures and practical clinical cases. It covers radiopharmaceutical application and clinical trials, the establishment and improvement of radionuclide diagnosis and treatment centers, and the application of radionuclide diagnosis and treatment in thyroid cancer, neuroendocrine tumors, and prostate cancer. At the invitation of Professor Yan Xuexian, co-chair of the course, Professor Chen Jie from Shanghai Cancer Hospital and Professor Chen Haojun from Xiamen University gave lectures on the systematic treatment of neuroendocrine tumors and the application of FAPI based radionuclide therapy respectively, which benefited the participants a lot. Participants from China also included Dr. Yao Xiaochen from Nanjing First Hospital, Director Zhang Wei from Sichuan Provincial People's Hospital, Professor Liu Xuemei from Zunyi Medical University, Professor Wang Li and Dr. Zheng Wenlu from the Affiliated Hospital of Southwest Medical University. They participated seriously in the meeting, actively spoke, and contributed their experience and wisdom.

       This is the first time that this prestigious oncology course has been held outside Europe, and it promotes understanding and collaboration among the various disciplines of clinical oncology on nuclear medicine imaging and treatment.